2019
DOI: 10.21769/bioprotoc.3431
|View full text |Cite
|
Sign up to set email alerts
|

Leishmania Parasite Quantification by Bioluminescence in Murine Models

Abstract: Leishmaniasis remains a major public health problem worldwide with a prevalence of 12 million, an incidence of 1 million persons, and 350 million people being at risk. Murine models have been largely used for studying the host-pathogen relationship and developing effective chemotherapies against Leishmania parasites. Thus, preclinical imaging is crucial for monitoring the disease outcome.The aim of this protocol is to quantify parasite burden using bioluminescence in vivo imaging. Here, we describe a high-thro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 7 publications
0
7
0
Order By: Relevance
“…with 200 mg/kg of Luminol sodium salt (Carbosynth) or 150 mg/kg of VivoGlo Luciferin (Promega) diluted in dPBS, respectively. Bioluminescence from mouse footpads was measured by In-vivo Xtreme II (BRUKER) and quantified using Molecular Imaging (MI) software (BRUKER) as described previously ( 40 ).…”
Section: Methodsmentioning
confidence: 99%
“…with 200 mg/kg of Luminol sodium salt (Carbosynth) or 150 mg/kg of VivoGlo Luciferin (Promega) diluted in dPBS, respectively. Bioluminescence from mouse footpads was measured by In-vivo Xtreme II (BRUKER) and quantified using Molecular Imaging (MI) software (BRUKER) as described previously ( 40 ).…”
Section: Methodsmentioning
confidence: 99%
“…Immunocompromised mice, such as Ifng -/- and dKO mice, received constant pain medication (1g/L Dafalgan (Upsa) diluted in drinking water) during the second half of their infection. In vivo parasite burden was quantified by intra-peritoneally injecting VivoGlo Luciferin (Promega) at a concentration of 150 mg/kg and measuring the bioluminescence produced in the mouse footpads with In-Vivo Xtreme II (BRUKER) as previously described [ 94 ]. Alternatively, in vivo ROS levels were measured by intra-peritoneally injecting Luminol sodium salt (Carbosynth) at a concentration of 200 mg/kg and following the same procedure as parasite burden quantification.…”
Section: Methodsmentioning
confidence: 99%
“…The acquired images were analyzed using Molecular Imaging (MI) software (BRUKER). Regions of Interest (ROI) were set on the footpads and the bioluminescent signals were expressed in units of photons per second (P/s) [ 94 ].…”
Section: Methodsmentioning
confidence: 99%
“…Parasite burden was quantified in the infected mice by injecting VivoGlo D-Luciferin salt (Promega) at a concentration of 150 mg/kg, intraperitoneally (i.p. ), and parasite bioluminescence produced in the mouse footpads and other visible secondary lesions (like tail and snout) were measured with In-Vivo Xtreme II (BRUKER) as previously described (Reverte and Fasel, 2019). Additionally, in vivo read out of inflammation was measured similarly by injecting Luminol sodium salt (Carbosynth) at a concentration of 200 mg/kg i.p.…”
Section: Mice Infection and In Vivo Bioluminescence Imaging And Quant...mentioning
confidence: 99%
“…These acquired images were then analyzed using Molecular Imaging (MI) software (BRUKER), setting specific regions of interest (ROIs) on FP, tail, etc. and expressing the measured bioluminescence signals in units of photons per second (p/s) (Reverte and Fasel, 2019). Immunocompromised mice (Ifng −/− ) received constant painrelieving medication [1g/L DAFALGAN (Upsa) diluted in drinking water], from the appearance of big primary lesions (W3-4 p.i.)…”
Section: Mice Infection and In Vivo Bioluminescence Imaging And Quant...mentioning
confidence: 99%